Allergic reactions occur when the body's immune system
targets a normally harmless protein as if it were a
dangerous pathogen, leading to inflammation.
Stanford University School of Medicine scientists successfully defeated a
dangerous intestinal
pathogen, Clostridium difficile, with a drug
targeting its toxins rather than its life.